Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Iwai

Showing results (211-220 of 213) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 213 results.
BMJ Open|November 13, 2015
Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort studyS Misawa, Y Sato, K Katayama, et al.
The Journal of Experimental Medicine|October 4, 2000
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activationG J Freeman, A J Long, Y Iwai, et al.
Nature Immunology|February 27, 2001
PD-L2 is a second ligand for PD-1 and inhibits T cell activationY Latchman, C R Wood, T Chernova, et al.
Pageof 22

Showing results (211-220 of 213) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 213 results.
BMJ Open|November 13, 2015
Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort studyS Misawa, Y Sato, K Katayama, et al.
The Journal of Experimental Medicine|October 4, 2000
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activationG J Freeman, A J Long, Y Iwai, et al.
Nature Immunology|February 27, 2001
PD-L2 is a second ligand for PD-1 and inhibits T cell activationY Latchman, C R Wood, T Chernova, et al.
Pageof 22